Why the study?
Do tissue IGFBP-2, -3, and -4 levels differ between colon cancer tissue and adjacent normal tissue, and do they correlate with clinicopathologic characteristics?
Population
102 patients with colorectal cancer who underwent operations between January 2004 and December 2006.
Comparison
Measurement of gene expressions of IGFBP-2, -3… vs Adjacent normal colon tissues
Design
Cross-sectional
Key result
The abstract is truncated and does not report quantitative results for the expression of IGFBP-2, -3, and -4 in colon cancer tissue compared to adjacent normal tissue.
Authors
Loading...
Absence of quantitative results limits immediate clinical utility; leaves open IGFBP roles in colon cancer progression.
Observational (n=102)
Do tissue IGFBP-2, -3, and -4 levels differ between colon cancer tissue and adjacent normal tissue, and do they correlate with clinicopathologic characteristics?
Kim et al. (2008) conducted an observational in colon cancer (n=102). Colon cancer tissue vs. Adjacent normal colon tissue was evaluated on Gene expressions of IGFBP-2, -3, -4. The abstract is truncated and does not report quantitative results for the expression of IGFBP-2, -3, and -4 in colon cancer tissue compared to adjacent normal tissue.